Navigation Links
The Female Health Company Reports Second Quarter Operating Results
Date:5/1/2012

ating cash flow has enabled the Company to expand FC2 production capacity to provide protection for even more women.  The expansion will be funded from the Company's cash on hand, which increased 48% to $6.3 million during the first six months of Fiscal 2012.  Our solid financial results and positive outlook have also permitted the Company to increase its cash dividend to its shareholders, whose support has made the female condom available."

Cost of sales increased 32% to $3.3 million in the second quarter of FY2012, compared with $2.5 million in the second quarter of FY2011. Gross profit increased 152% to $4.6 million, or 58% of net revenues, in the most recent quarter, compared with $1.8 million, or 42% of net revenues, in the second quarter of FY2011.

Operating expenses for the quarter ended March 31, 2012 increased 41% to $2.4 million when compared with operating expenses of $1.7 million in the second quarter of FY2011. The increase was primarily due to accrual for fiscal year-end incentive payments related to the expected achievement of unit sales and operating income targets, as well as increased travel, legal and consulting fees. Because the likelihood of the Company's FY2011 targets being met was uncertain at March 31, 2011, the second quarter FY 2011 bonus accrual was minimal.

Operating income increased 2,036% to $2.2 million in the three months ended March 31, 2012, compared with $0.1 million in the prior-year quarter. The increase reflects significantly increased gross profit resulting from higher unit sales, somewhat offset by higher operating expenses.

The Company reported net income of $1.9 million, or $0.07 per diluted share, in the second quarter of FY2012, a 2,251% increase over net income of $0.1 million, or $0.00 per diluted share, in the second quarter of FY2011. The Company recorded a currency loss of $0.03 million in each of the quarters ended March 31, 2012 and 2011.

For the six months ended
'/>"/>

SOURCE The Female Health Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
2. Palatin Technologies Completes Enrollment in Phase 2B Bremelanotide Female Sexual Dysfunction Trial
3. The Female Health Companys Distributor, Sekunjalo Investments Corporation (PTY) Ltd., Receives Order for 5 Million FC2 Female Condoms From the Republic of South Africa Department of Health
4. The Female Health Company to Host Third Quarter Conference Call on Friday, August 5, 2011
5. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
6. The Female Health Companys Brazilian Distributor, Semina, Awarded Contract For Up To 20 Million FC2 Female Condoms
7. The Female Health Company Declares 2nd Quarter Dividend of $0.05/share
8. The Me-Covery: Saatchi & Saatchi Wellness and Time Inc.s Health Brand Reveal Historic Shift in Female Consumer Behavior
9. Co-Promotion of a New Medical Device for Female Infertility Announced
10. The Female Health Company Receives Order for 3.5 Million FC2 Female Condoms for Distribution at 2010 World Cup
11. Second-Generation Female Condom is Now Available in the United States; FC2 Female Condom Will Cost 30 Percent Less than Predecessor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 Amerivet Solutions, LLC ... all branches of government from Federal to Municipal, ... their facilities to include complex metal design and ... some very complex aluminum parts for the Defense ... our capabilities to service government contracts," states ...
(Date:6/19/2013)... ZIONA, Israel , June ... announced that results from a phase I study in ... in advanced Parkinson,s patients, of ND0612, were presented at ... Disorders. ND0612 is a proprietary levodopa/carbidopa liquid drug formula ... delivery patch that would maintain constant levodopa plasma concentrations. ...
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- In its first major ... company dedicated to advancing development of the ... release drug therapies in patient disease populations ... the acquisition of Enzon Pharmaceutical,s PEGylation Linker ... product pipeline. Acquisition of this technology will ...
Breaking Medicine Technology:Amerivet Solutions Expands to Manufacture Complex Metal Designs 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
... 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the ... advanced in-vitro diagnostic ("IVD") company, today announced that it ... fiscal quarter ended June 30, 2011 ("1Q FY2011") before ... The Company,s senior management will host an earnings ...
... 4, 2011 Reportlinker.com announces that ... available in its catalogue: ... Markets, Players and Prospects ... Microneedle technology is an ...
Cached Medicine Technology:China Medical Technologies to Announce Results for the First Fiscal Quarter Ended June 30, 2011 on August 16, 2011 2Microneedle Drug Delivery: Technology, Devices, Markets, Players and Prospects 2Microneedle Drug Delivery: Technology, Devices, Markets, Players and Prospects 3
(Date:6/19/2013)... The former internist for the St. Louis Rams ... as director of prevention and wellness at St. Luke’s ... encounter with a metabolic syndrome diagnosis and a happenstance ... that he credits with sparking the paradigm-shift that has ... , “The average medical student gets 30 minutes of ...
(Date:6/19/2013)... June 19, 2013 “We are proud to ... nothing else like it in the U.S.,” says Shaun Johnson, ... an effective and inexpensive solution to a very expensive problem, ... their koi fish,” he adds. , Each package of ... to fit the shape of any water garden or pond. ...
(Date:6/19/2013)... 2013 The producers of Viewpoints TV ... Arizona. The city is located in the center of ... shed its frontier image and become an affordable city to ... fifth-largest city in the United States with a workforce strong ... residents a low cost-of-living, friendly business environment and more than ...
(Date:6/19/2013)... the incidence of cancer is many fold higher in ... an inadequate understanding on how best to treat these ... occasionally included in clinical trials, those elderly patients who ... Thus, the broader elderly patient population is not well ... Elderly Task Force is now starting a new phase ...
(Date:6/19/2013)... June 19, 2013 The Cancer Support ... promise of cancer care for the whole patient with ... the Cancer Support Community. This inaugural event, held at ... Emanuel, MD., Ph.D., recognition of Congress members who have ... voices of patients and families currently engaged in the ...
Breaking Medicine News(10 mins):Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 3Health News:Viewpoints TV Announces June Air Dates for Phoenix, AZ 2Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 2Health News:Keeping the Promise of Cancer Care for the Whole Patient 3
... of the hallucinogen psilocybin, the active ingredient in so-called ... personality change lasting at least a year in nearly ... study, according to the Johns Hopkins researchers who conducted ... of the personality known as openness, which includes traits ...
... , WEDNESDAY, Sept. 28 (HealthDay News) -- Cancer patients ... can have serious side effects and even mean the ... crucial that patients insist doctors use plain language ... associate professor of internal medicine at the University of ...
... a patient,s own stem cells, researchers at Johns Hopkins have ... a painful, disabling inherited blood disorder that affects mostly African-Americans. ... cells in a test tube that then turned on a ... cautions that the work, done only in the laboratory, is ...
... Researchers at the Stanford University School of Medicine have ... activation patterns in children with poor reading skills and ... readers with a typical IQ. The work provides more ... difficulties regardless of their general cognitive ability. Schools ...
... large-scale study on cat intestinal cancer has provided new insight ... could ultimately benefit humans. "We are looking for patterns ... risk factors," said Kim Selting, associate teaching professor of oncology ... former resident, Kerry Rissetto, as she examined intestinal tumors in ...
... at the University of California, San Francisco (UCSF) Medical Center ... occurs as healthy brain cells begin to form tumors. ... a common type of brain tumor, at its earliest stage, ... will have to prove safe and effective in clinical trials, ...
Cached Medicine News:Health News:Single dose of hallucinogen may create lasting personality change 2Health News:Single dose of hallucinogen may create lasting personality change 3Health News:Cancer Patients Should Ask Doctors to Use Simple Terms 2Health News:Correcting sickle cell disease with stem cells 2Health News:Stanford brain imaging study shows physiological basis of dyslexia 2Health News:Stanford brain imaging study shows physiological basis of dyslexia 3Health News:University of Missouri study finds risk factors for cat cancer, could have human implications 2Health News:How normal cells become brain cancers 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: